Modernising histopathology for better breast cancer care
This journey starts with accurate diagnosis: and that is where MammaTyper® comes in.
May 22nd - World Pre-Eclampsia Day
Early diagnosis of Pre-Eclampsia can save lives.
International Woman's Day - 8th March 2022
International Women’s Day is a time to celebrate the social, economic, cultural and political achievements of women everywhere. This year, the focus is on how to #breakthebias
Cerca Biotech
Cerca Biotech is the European subsidiary of Shuwen Biotech, who you might already recognise as being a highly reputable and innovative molecular and point of care diagnostics organisation.
Mamma Typer®
it’s time to take the stage.
MammaTyper® is a new tool for subtyping breast cancer.
READ MORE +
A rapid, simple, Point Of Care screening test for urinary congophilia.
READ MORE +ABOUT US
Cerca Biotech
Cerca Biotech is the European subsidiary of Shuwen Biotech, a highly reputable and innovative molecular and point of care diagnostics organisation. Shuwen and Cerca are passionate about healthcare and are working to create world-leading innovations in the fields of Oncology and Women’s Health.
High-performance test
Quantitative RT-qPCR assay (CE marked IVD)
- Highly reproducible biomarker assessment
- Reliable results through standardized biomarker detection
- Accurate stratification of breast cancer tumors into St Gallen subtypes
Promising clinical utility
Clinical value validated in numerous performance evaluation studies
- Outperforms IHC by accurate Ki-67 determination
- Provides information on patient‘s prognosis
- Accurate subtyping supports treatment decisions
Easy-to-use
Clinical value validated in numerous performance evaluation studies
- Reliable method for any molecular pathology laboratory
- Validated for multiple qPCR instruments*
- From resection or core needle biopsy FFPE sample to result within 6 hours FFPE = formalin fixed paraffin embedded
NEWS
Recent article and news
October, Breast Cancer Awareness Month
It’s October, which means it’s Breast Cancer Awareness month. This journey starts with accurate diagnosis: and that is where MammaTyper® comes in.
Ki-67; Love it or Hate it?
Ki-67 is a great aid in the diagnosis and treatment of a variety of cancers. If you are a patient looking for more information, you might find this article a bit technical, but you can still head on over to cercabiotech.com for our patient-focussed information which we hope can help.
World Pre Eclampsia Day (May 22nd)
Early diagnosis of Pre-Eclampsia can save lives. Yet, definitive detection of this potentially fatal condition can be delayed or difficult to access under current testing regimes. To help combat this issue, Cerca Biotech is launching a new, rapid point-of-care test designed for use in maternity departments and primary care settings.